TheStreet Network:
TheStreet
|
MainStreet
|
BankingMyWay
|
RealMoney
Home
About Stockpickr
|
How to Use
Portfolios
Professional
Warren Buffett
George Soros
T. Boone Pickens
Carl Icahn
» Most-Viewed
» Recently Updated
Stockpickr Spotlight
9 Oil Refining Stocks to Watch
Five Best-Performing Biotech Stocks of 2013
4 Turnarounds Poised for better days Ahead
Zombie Apocalypse Portfolio
5 Small-Cap Bank Stock Plays for 2013 From Credit Suisse
» More Spotlight Portfolios
User Generated
Recently Updated
Tools
Market Indicators
Top % Gainers
Top % Losers
52-Week Highs
52-Week Lows
Rising on Unusual Volume
Unusual Options Activity
Upgrades and Downgrades
Analyst Upgrades
Analyst Downgrades
TheStreet Ratings Upgrades
TheStreet Ratings Downgrades
Daily Lists
Cramer's "Lightning Round"
Insider Buying
Insider Selling
Earnings Announcements
Ex-Dividend Stocks
Dogs of the Dow
Articles
5 Stocks Under $10 Making Big Moves
3 Health Care Stocks Under $10 to Watch
5 Stocks Poised to Pop on Bullish Earnings
5 Buy Signals From the Consumer Sector
3 Stocks Rising on Unusual Volume
» More Articles
My Stockpickr
Log In
|
Join for Free
Stock Game
Health Care: Drugs
Onyx Pharmaceuticals Inc. (ONXX: NASDAQ)
$88.80
-1.18 | -1.31%
06/18/13 - 04:00 PM ET
Quote
Ratings
Earnings
Fundamentals
Options Chain
Advanced Chart
Balance Sheet
Cash Flow
Income Statement
Growth Rates
Major Holders
Ratio Comparison
Portfolios with
ONXX
Portfolio Name
User Type
Contributor
Stocks Rising On Unusual Vo...
Contributor
Stocks Rising On Unusual Vo...
Contributor
Stocks Rising On Unusual Vo...
Contributor
4 Drug Stocks Facing FDA Ap...
Contributor
Hot Biotech Stocks Traded b...
Contributor
Stocks Rising On Unusual Vo...
User
players
Contributor
Breakout Stocks Of The Week...
Contributor
Earnings Short Squeeze Play...
Contributor
Stocks Rising On Unusual Vo...
View All
Latest
ONXX
Headlines from TheStreet
Onyx Reaches New 52-Week High (ONXX)
04.10.13 | 10:04 am
Market Takes Aim at Historic Highs Once Again
04.10.13 | 09:04 am
Cramer's Top Stock Picks: QQQ IMGN SGEN ONXX
04.05.13 | 06:04 am
Onyx Pharmaceuticals Inc. (ONXX): Drugs' Highlighted Dud Of The Day
04.04.13 | 05:04 pm
8 Stocks Surging on Big Volume
04.01.13 | 03:04 pm
Analysts' Actions: INTC ONXX VRSN Z RHAT
03.28.13 | 09:03 am
Onyx Pharmaceuticals Inc. (ONXX): Today's Highlighted Performer In Drugs
03.25.13 | 05:03 pm
8 Stocks With Buy Ratings From Deutsche Bank And UBS
03.14.13 | 01:03 pm
Onyx Rises On Unusually High Volume (ONXX)
03.07.13 | 04:03 pm
The Next Big Thing In Biotech: Onyx
03.07.13 | 01:03 pm
More Financial News for ONXX
Press Releases for
ONXX
Phase 3 DECISION Trial Investigating The Use Of Nexavar® (sorafenib) Demonstrated Significant Improvement In Progression-Free Survival In Patients With Radioactive Iodine-Refractory Differentiated Thyroid Cancer
- PR Newswire 06.02.13 | 07:06 am
Bayer's Stivarga® (regorafenib) Tablets Approved In Japan
- PR Newswire 03.25.13 | 05:03 pm
Bayer's Stivarga® (regorafenib) Tablets Approved By U.S. FDA For Treatment Of Patients With Locally Advanced, Unresectable Or Metastatic GIST
- PR Newswire 02.25.13 | 04:02 pm
Onyx Pharmaceuticals Launches Make Your Mark At The Multiple Myeloma Experience To Champion Progress In Multiple Myeloma Research And Treatment
- PR Newswire 12.06.12 | 04:12 pm
Onyx Pharmaceuticals To Present At Upcoming Investor Conferences
- PR Newswire 09.04.12 | 04:09 pm
Bayer Submits New Drug Application For Regorafenib For The Treatment Of Gastrointestinal Stromal Tumors (GIST)
- PR Newswire 08.30.12 | 10:08 am
Onyx Pharmaceuticals Announces Kyprolis⢠Study Published In The Medical Journal Blood
- PR Newswire 07.25.12 | 09:07 am
Onyx Pharmaceuticals To Report Second Quarter 2012 Financial Results After Market On August 1, 2012
- PR Newswire 07.23.12 | 04:07 pm
Addition Of Tarceva® (erlotinib) To Nexavar® (sorafenib) Did Not Provide Additional Benefit To Patients With Unresectable Liver Cancer Versus Nexavar Alone In Phase 3 Trial
- PR Newswire 07.23.12 | 02:07 am
Onyx Pharmaceuticals Receives FDA Accelerated Approval Of Kyprolis⢠(carfilzomib) For Injection
- PR Newswire 07.20.12 | 12:07 pm
See All Press Releases
Partner Headlines for
ONXX
Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB)
- Benzinga 06.12.13 | 01:06 pm
Onyx Phase 3 Nexavar DECISION Trial Shows Significant Improvement in Progression-Free Survival in Patients with Radioactive Iodine-Refractory Differentiated Thyroid Cancer
- Benzinga 06.02.13 | 09:06 am
Onyx Pharma to Hold Call to Discuss Phase 3 DECISION Data at 2013 ASCO
- Benzinga 05.31.13 | 04:05 pm
Short Interest in Vertex Rises, in Celgene Falls
- Benzinga 05.11.13 | 10:05 am
Pharmacyclics Inc. (PCYC): Today's Most Compelling Stock Buy
- NASDAQ 05.07.13 | 05:05 pm
Onyx Pharmaceuticals Earnings: Here’s Why Investors are Buying Shares Now
- Wall St. Cheat Sheet 05.07.13 | 06:05 am
Polycyclics Inc. (PCYC): Today's Most Compelling Stock Pick
- NASDAQ 04.26.13 | 07:04 pm
Deutsche Bank Reiterates Buy on Onyx Pharmaceuticals on Updated Guidelines
- Benzinga 03.11.13 | 01:03 pm
Four Biotech Stocks On The Clock
- Seeking Alpha 02.19.13 | 09:02 am
Onyx Pharmaceuticals (ONXX) - Bull of the Day
- Zacks 12.05.12 | 01:12 am
Refresh Stock Quote for Onyx Pharmaceuticals Inc. - ONXX
The Value of Stillness
Drugs IPOs Depend o...
Up Day as Wall Stre...
Home
About Stockpickr
How to Use
Join for FREE
STOCK GAME
Portfolios
Professional
Warren Buffett
George Soros
T. Boone Pickens
Carl Icahn
Most-Viewed
Recently Updated
Stockpickr Spotlight
9 Oil Refining Stocks to Watch
Five Best-Performing Biotech Stocks of 2013
4 Turnarounds Poised for better days Ahead
Zombie Apocalypse Portfolio
5 Small-Cap Bank Stock Plays for 2013 From Credit Suisse
More Spotlight Portfolios
User Generated
Recently Updated
Tools
Market Indicators
Top % Gainers
Top % Losers
52-Week Highs
52-Week Lows
Rising on Unusual Volume
Unusual Options Activity
Upgrades and Downgrades
Analyst Upgrades
Analyst Downgrades
TheStreet Ratings Upgrades
TheStreet Ratings Downgrades
Daily Lists
Cramer's "Lightning Round"
Insider Buying
Insider Selling
Earnings Announcements
Ex-Dividend Stocks
Dogs of the Dow
Articles
5 Stocks Under $10 Making Big Moves
3 Health Care Stocks Under $10 to Watch
5 Stocks Poised to Pop on Bullish Earnings
5 Buy Signals From the Consumer Sector
3 Stocks Rising on Unusual Volume
More Articles
My Stockpickr
My Stockpickr Profile
Inbox
Add New Portfolio
Edit My Profile